First Time Loading...
V

Vifor Pharma AG
SIX:VIFN

Watchlist Manager
Vifor Pharma AG
SIX:VIFN
Watchlist
Price: 166.15 CHF 0.48% Market Closed
Updated: May 17, 2024

Vifor Pharma AG
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vifor Pharma AG
Pre-Tax Income Peer Comparison

Comparables:
NOVN
NLSP
ROG
S
SDZ

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
V
Vifor Pharma AG
SIX:VIFN
Pre-Tax Income
CHf311.7m
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
0%
Novartis AG
SIX:NOVN
Pre-Tax Income
$12.3B
CAGR 3-Years
8%
CAGR 5-Years
-2%
CAGR 10-Years
1%
NLS Pharmaceutics AG
NASDAQ:NLSP
Pre-Tax Income
-$16.5m
CAGR 3-Years
-45%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Roche Holding AG
SIX:ROG
Pre-Tax Income
CHf14.1B
CAGR 3-Years
-8%
CAGR 5-Years
0%
CAGR 10-Years
0%
S
Sandoz Group AG
SIX:SDZ
Pre-Tax Income
$1.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Vifor Pharma AG's Pre-Tax Income?
Pre-Tax Income
311.7m CHF

Based on the financial report for Dec 31, 2021, Vifor Pharma AG's Pre-Tax Income amounts to 311.7m CHF.

What is Vifor Pharma AG's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
0%

Over the last year, the Pre-Tax Income growth was 18%. The average annual Pre-Tax Income growth rates for Vifor Pharma AG have been 5% over the past three years , 7% over the past five years .